BBCR Voice
From the Perspective of Researchers, Clinicians, and Regulatory Experts
The most efficient path in the clinical research process is a moving target. Technology innovation and regulatory requirements require constant updates. Through BBCR Voice, we aim to share not only our knowledge and expertise but also solutions to current challenges. BBCR embraces the challenges of developers and investors seeking a more straightforward path to market.
Recent Posts
Strategies that De-Risk Clinical Trials
Why clinical strategy is important for clinical trial success. Since the 1990s, the pharma industry has experienced increasing R&D expenditure and number of candidates entering development. The average number of news drugs approved by FDA per year, however, has...
Strategic Consulting: The convergence revolution to innovate clinical trial process
SCIO Strategic Consulting Convergence is the results of sharing methods and ideas across multidisciplinary fields of science and industries. The Convergence revolution, despite is challenged by industry, educational and government constrains, offers a real solution to...
Strategic Consulting – SCIO Process -A New Way for Drug Development
SCIO Strategic Consulting SCIO is critical to accelerate approval and significantly reduce costs. Declining pharmaceutical industry productivity is well recognized by drug developers, regulatory authorities and patient groups. Despite the fast growth of the sector,...
Strategic consulting reduces cost and risk of clinical trials
SCIO Strategic Consulting The Strategic Clinical Innovation Organization (SCIO) concept provides biotech, pharmaceutical and device companies with a cost-effective, customized approach to clinical development. This approach, pioneered by BBCR, reduces the risks...
SCIO Helps Early Stage Biotech Company Evaluation
SCIO Strategic Consulting The creation of the concept for a Strategic Clinical Innovation Organization (SCIO) has been evolving over the past 10 years as the market has become aware of the risk from the lack of “upfront” clinical strategy and development...
A success story by BBCR Consulting: Candida Fratazzi MD was CMO at Ichorion Therapeutics in 2018
Thanks to strategic and expert work focused on product positioning and development with risk reduction, in only 8 months, Ichorion Therapeutics was acquired by Cerecor. Transaction worth approximately $26.6 Million in Stock Plus Potential Milestones Accelerates...
Welcome to BBCR’s New Website!
We are pleased to share with you our new website. Over the past several months, our team has carefully reviewed our processes, capabilities, and offerings in order to provide you with the clearest overview of how we help our clients. The SCIO approach we take in...